Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis. (Q42449223)
Jump to navigation
Jump to search
scientific article published on November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis. |
scientific article published on November 2008 |
Statements
Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis (English)
M Cuchacovich
D Catalan
E Wainstein
H Gatica
L Soto
O Aravena
B Pesce
F Sabugo